Makers Laboratories Intrinsic Value
Makers Laboratories (MAKERSL) median intrinsic value is ₹322.00 from 4 valuation models (range ₹64–₹383), vs current price ₹161.00 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Also explore MAKERSL share price charts to track price trends across different timeframes.
MAKERSL Valuation Methods Summary — DCF, Graham Number & P/E
Makers Laboratories intrinsic value across 4 models vs current price ₹161.00 — upside/downside and value range per method. For current market price and key ratios, visit Makers Laboratories screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹383.33 | ₹345.00 - ₹421.66 | +138.1% | Book Value/Share: ₹191.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹322.00 | ₹289.80 - ₹354.20 | +100.0% | Revenue/Share: ₹233.33, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹200.00 | ₹180.00 - ₹220.00 | +24.2% | EBITDA: ₹12.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹64.40 | ₹51.52 - ₹77.28 | -60.0% | CF Growth: 5.0%, Discount: 15% |
MAKERSL Intrinsic Value vs Market Price — All Valuation Models
Makers Laboratories fair value range ₹64–₹383 vs current market price ₹161.00 across 4 valuation models. Browse Makers Laboratories financial data for revenue, profit, balance sheet and cash flow data.
MAKERSL Intrinsic Value Analysis — Undervalued or Overvalued?
Makers Laboratories median intrinsic value ₹322.00, current price ₹161.00 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of MAKERSL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Makers Laboratories (MAKERSL) is ₹322.00 (median value). With the current market price of ₹161.00, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹64.40 to ₹383.33, indicating ₹64.40 - ₹383.33.
Is MAKERSL undervalued or overvalued?
Based on our multi-method analysis, Makers Laboratories (MAKERSL) appears to be trading below calculated value by approximately 100.0%.
MAKERSL Financial Health — Key Ratios vs Industry Benchmarks
Makers Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.67 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
MAKERSL Cash Flow Quality — Operating & Free Cash Flow
Makers Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-9 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹19 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |